• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真实世界临床实践中与年龄相关的不明来源栓塞性卒中的负担和特征。

Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.

机构信息

Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Florence, Italy.

Cardiology, San Giuseppe Hospital, Empoli, Florence, Italy.

出版信息

J Thromb Thrombolysis. 2020 Jan;49(1):75-85. doi: 10.1007/s11239-019-01951-5.

DOI:10.1007/s11239-019-01951-5
PMID:31494844
Abstract

Few data are available on age-related burden and characteristics of embolic stroke of undetermined source (ESUS) in the real world clinical practice. The aim of our study was to provide information about it. We retrospectively analyzed data of patients consecutively admitted to our Stroke Unit along 1 year (2017, November 1st-2018, October 31st). The etiology of ischemic stroke was defined at hospital discharge; ESUS was considered as a subset of cryptogenic stroke, and defined according to the 2014 international criteria. In the analyzed period, 306 patients, 52.3% females, mean age ± SD 77.9 ± 11.9 years, were discharged with diagnosis of ischemic stroke. Ischemic strokes of cardioembolic and lacunar origin were the most frequent subtypes: 30.1% and 29.4%, respectively. Cardioembolic strokes were particularly frequent in patients ≥ 75 years, and almost always associated with atrial fibrillation. Overall, in 80 patients (26.1%) the etiology of stroke was undetermined; in 25 (8.2%) it remained undefined because of death or severe comorbidity, making further diagnostic work-up not worthy. Cryptogenic stroke occurred in 55 patients (18%), and ESUS criteria were satisfied in 39 of them (12.7%). According to age, cryptogenic stroke was diagnosed in 21.1% (21.1% ESUS) of patients < 65 years, 24.2% (19.4% ESUS) of patients aged 65-74 years, 15.5% (9.2% ESUS) of patients ≥ 75 years. After diagnostic work-up, patent foramen ovale was most commonly associated with ESUS (17.9%), especially in patients < 65 years (62.5%); covert paroxysmal atrial fibrillation was detected in 10.5% of ESUS patients ≥ 75 years. In the real world clinical practice, the frequency of ischemic strokes of undetermined etiology, and of those satisfying ESUS criteria, is not negligible, especially in younger patients. A thorough diagnostic work-up, with an age-specific approach, is therefore necessary and of the utmost importance for the identification of stroke etiology, in order to optimize secondary stroke prevention strategies.

摘要

关于实际临床实践中不明来源栓塞性卒中(ESUS)的年龄相关负担和特征,相关数据有限。我们的研究旨在提供相关信息。我们回顾性分析了 1 年内(2017 年 11 月 1 日至 2018 年 10 月 31 日)连续收治于我们卒中病房的患者数据。患者出院时明确缺血性卒中病因;ESUS 被视为隐源性卒中的一个亚组,并根据 2014 年国际标准进行定义。在分析期间,306 名患者(52.3%为女性)出院时被诊断为缺血性卒中,平均年龄为 77.9±11.9 岁。心源性和腔隙性来源的缺血性卒中是最常见的亚型:分别为 30.1%和 29.4%。心源性卒中在≥75 岁的患者中尤为常见,且几乎总是与心房颤动相关。总的来说,80 名患者(26.1%)的卒中病因不明;由于死亡或严重合并症,25 名患者(8.2%)的病因仍未明确,因此进一步的诊断检查是不值得的。55 名患者(18%)被诊断为隐源性卒中,其中 39 名(12.7%)符合 ESUS 标准。根据年龄,<65 岁的患者中有 21.1%(21.1%为 ESUS)、65-74 岁的患者中有 24.2%(19.4%为 ESUS)、≥75 岁的患者中有 15.5%(9.2%为 ESUS)被诊断为隐源性卒中。经过诊断性检查,卵圆孔未闭是最常与 ESUS 相关的病因(17.9%),尤其是在<65 岁的患者中(62.5%);在≥75 岁的 ESUS 患者中,检测到 10.5%的隐匿性阵发性心房颤动。在实际临床实践中,不明病因的缺血性卒中和符合 ESUS 标准的缺血性卒中的频率不可忽视,尤其是在年轻患者中。因此,需要进行全面的诊断性检查,并采用特定年龄的方法,以明确卒中病因,从而优化二级卒中预防策略。

相似文献

1
Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.真实世界临床实践中与年龄相关的不明来源栓塞性卒中的负担和特征。
J Thromb Thrombolysis. 2020 Jan;49(1):75-85. doi: 10.1007/s11239-019-01951-5.
2
Embolic strokes of undetermined source in a cohort of Polish stroke patients.波兰卒中患者队列中的不明来源栓塞性卒中。
Neurol Sci. 2018 Jun;39(6):1041-1047. doi: 10.1007/s10072-018-3322-5. Epub 2018 Mar 19.
3
Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source.不明来源栓塞性卒中伴隐匿性心房颤动的差异特征、卒中复发及预测因素。
Int J Stroke. 2018 Feb;13(2):190-194. doi: 10.1177/1747493017724624. Epub 2017 Jul 31.
4
Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.雅典卒中登记中不明来源的栓塞性卒中:一项描述性分析。
Stroke. 2015 Jan;46(1):176-81. doi: 10.1161/STROKEAHA.114.007240. Epub 2014 Nov 6.
5
Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.评估不明来源栓塞性卒中的青年患者中复发性缺血性卒中的发生率:青年 ESUS 纵向队列研究。
JAMA Neurol. 2022 May 1;79(5):450-458. doi: 10.1001/jamaneurol.2022.0048.
6
Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.隐匿性心房颤动和心房高频率发作作为不明来源栓塞性卒中的潜在病因:其检测及可能的管理策略
J Cardiol. 2018 Jul;72(1):1-9. doi: 10.1016/j.jjcc.2018.03.002. Epub 2018 Mar 31.
7
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry.不明来源栓塞性卒中:ESUS全球注册研究中的患病率及患者特征
Int J Stroke. 2016 Jul;11(5):526-33. doi: 10.1177/1747493016641967. Epub 2016 Apr 11.
8
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.不明来源栓塞性卒中后复发缺血性卒中的特征:一项随机临床试验的二次分析。
JAMA Neurol. 2020 Oct 1;77(10):1233-1240. doi: 10.1001/jamaneurol.2020.1995.
9
The ASCOD Phenotyping of Embolic Strokes of Undetermined Source.不明来源栓塞性卒中的 ASCOD 表型。
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104491. doi: 10.1016/j.jstrokecerebrovasdis.2019.104491. Epub 2019 Nov 21.
10
From cryptogenic to ESUS: Toward precision medicine?从隐源性到 ESUS:走向精准医学?
Rev Neurol (Paris). 2022 Nov;178(9):939-952. doi: 10.1016/j.neurol.2022.01.016. Epub 2022 May 18.

引用本文的文献

1
The evolution of acute stroke care in Germany from 2019 to 2021: analysis of nation-wide administrative datasets.2019年至2021年德国急性中风护理的演变:对全国行政数据集的分析。
Neurol Res Pract. 2024 Jan 11;6(1):4. doi: 10.1186/s42466-023-00297-x.
2
Oxidative stress as a bridge between age and stroke: A narrative review.氧化应激作为年龄与中风之间的桥梁:一篇叙述性综述。
J Intensive Med. 2023 Mar 27;3(4):313-319. doi: 10.1016/j.jointm.2023.02.002. eCollection 2023 Oct 31.
3
Radiomics-based intracranial thrombus features on preoperative noncontrast CT predicts successful recanalization of mechanical thrombectomy in acute ischemic stroke.

本文引用的文献

1
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.达比加群酯预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
2
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.依房颤预测因子评估,利伐沙班与阿司匹林比较用于复发性卒中: NAVIGATE ESUS 随机临床试验的二次分析。
JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617.
3
Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
基于放射组学的术前非增强CT颅内血栓特征可预测急性缺血性卒中机械取栓的再通成功情况。
Quant Imaging Med Surg. 2023 Feb 1;13(2):682-694. doi: 10.21037/qims-22-599. Epub 2023 Jan 2.
4
Review and update of the concept of embolic stroke of undetermined source.不明来源栓塞性卒中概念的回顾与更新。
Nat Rev Neurol. 2022 Aug;18(8):455-465. doi: 10.1038/s41582-022-00663-4. Epub 2022 May 10.
5
Factors Influencing Recanalization After Mechanical Thrombectomy With First-Pass Effect for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.急性缺血性卒中机械取栓首次通过效应后再通的影响因素:一项系统评价和Meta分析
Front Neurol. 2021 Apr 9;12:628523. doi: 10.3389/fneur.2021.628523. eCollection 2021.
直接口服抗凝剂在非瓣膜性心房颤动相关急性缺血性卒中的早期治疗:关注真实世界研究。
J Thromb Thrombolysis. 2019 Feb;47(2):292-300. doi: 10.1007/s11239-018-1775-2.
4
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.利伐沙班或阿司匹林治疗卵圆孔未闭伴不明来源栓塞性卒中:NAVIGATE ESUS 试验的预先设定亚组分析。
Lancet Neurol. 2018 Dec;17(12):1053-1060. doi: 10.1016/S1474-4422(18)30319-3. Epub 2018 Sep 28.
5
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.不明原因卒中后心房心肌病和抗血栓药物预防的随机试验:原理和方法。
Int J Stroke. 2019 Feb;14(2):207-214. doi: 10.1177/1747493018799981. Epub 2018 Sep 10.
6
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.利伐沙班预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
7
A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source.一个用于预测不明来源栓塞性卒中后门诊心脏监测阵发性心房颤动的简单评分
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1692-1696. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.028. Epub 2018 Feb 28.
8
Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad?心房心肌病:心脏疾病管理中的有用概念,还是昙花一现?
J Am Coll Cardiol. 2017 Aug 8;70(6):756-765. doi: 10.1016/j.jacc.2017.06.033.
9
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.ASSERT 中设备检测到的无症状性心房颤动持续时间与卒中发生情况。
Eur Heart J. 2017 May 1;38(17):1339-1344. doi: 10.1093/eurheartj/ehx042.
10
Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.不明来源栓塞性卒中:系统评价与临床进展
Stroke. 2017 Apr;48(4):867-872. doi: 10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6.